Thermo Fisher Scientific Inc. (BVMF:TMOS34)
64.43
-0.13 (-0.20%)
At close: Dec 3, 2025
Thermo Fisher Scientific Revenue
Thermo Fisher Scientific had revenue of $11.12B USD in the quarter ending September 27, 2025, with 4.94% growth. This brings the company's revenue in the last twelve months to $43.74B, up 3.22% year-over-year. In the year 2024, Thermo Fisher Scientific had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$43.74B
Revenue Growth
+3.22%
P/S Ratio
4.95
Revenue / Employee
$349.89K
Employees
125,000
Market Cap
1.16T BRL
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Empreendimentos Pague Menos | 14.27B |
| Diagnósticos da América | 12.57B |
| Fleury | 8.07B |
| Hypera | 6.97B |
| Oncoclínicas do Brasil Serviços Médicos | 5.94B |
| Dimed S.A. Distribuidora de Medicamentos | 5.29B |